Mounjaro! weight loss injection!
Mounjaro Injection (tirzepatide)
Mounjaro (Tirzepatide), an injectable drug used in individuals with Type 2 Diabetes, to control blood sugars, aids in weight loss.
What is a Mounjaro (tirzepatide) injection?
Mounjaro is an injectable prescription medicine that is used in patients with Type 2 Diabetes along with diet and exercise to control blood sugars.
It functions as a dual agonist, targeting both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action enhances insulin sensitivity, helps regulate blood sugar levels, and can reduce appetite, making it beneficial for weight management.
How does Mounjaro helps in weight loss?
Mounjaro works in multiple ways it helps
- The body to release insulin when blood sugar is high
- Removes excess sugar from the blood
- Stops the liver from making and releasing too much sugar
- Suppress Appetite: It slows down the digestive process, helping you feel fuller for longer, thus reducing overall calorie intake.
- Slow down how quickly food leaves the stomach.
By acting on hunger-regulating hormones, it decreases food cravings
Recommendations for Mounjaro in weight loss:
Tirzepatide/ Mounjaro is recommended as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity, in adults, only if they have:
- an initial body mass index (BMI) of at least 35 kg/m2 and
- at least 1 weight-related comorbidity.
- Mounjaro is administered as a subcutaneous injection, typically in the thigh, abdomen, or upper arm.
- Your healthcare provider will guide you on the appropriate starting dose and adjustments.
- Usually given once a week, on the same day each week.
- Do notmix insulin and Mounjaro together in the same injection.
- It is acceptable to inject Mounjaro and Insulin in the same body region, but the injections should not be adjacent to each other.
- Change (rotate) your injection site with each weekly injection. Do notuse the same site for each injection.
- If you take too much Mounjaro, call your healthcare provider or seek medical advice promptly.
How to decide whether Mounjaro is safe for you?
Before opting for Mounjaro ask yourself whether you have any of the following concerns, and discuss with healthcare professional for decision
- Do you take other diabetes medicines, such as insulin or sulfonylureas?
- Do you have a history of diabetic retinopathy?
- Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
- Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? It is not known if Mounjaro will harm your unborn baby or pass into your breast milk.
- Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
Who should not take Mounjaro injection?
- If you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
- People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- If you are allergic to any of the ingredients in Mounjaro.
- People with Type 1 Diabetes
- Age < 18 years (safety โ unknown)
- Mounjaro may cause tumours in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
MounjaroโClinical results
In studies, participants using Mounjaro for weight management showed significant weight reduction compared to those using other treatments or a placebo. Some users experienced weight losses of up to 15-22% of their body weight over several months, though individual results can vary.
Hepatits B virus! Hepatitis B vaccine at home! Hepatitis infection!
Common inquiries regarding Mounjaro (Tirzepatide)
Mounjaro is an injectable prescription medicine that is used in patients with Type 2 Diabetes along with diet and exercise to control blood sugars.
It functions as a dual agonist, targeting both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action enhances insulin sensitivity, helps regulate blood sugar levels, and can reduce appetite, making it beneficial for weight management.
Mounjaro works in multiple ways it helps
- The body to release insulin when blood sugar is high
- Removes excess sugar from the blood
- Stops the liver from making and releasing too much sugar
- Suppress Appetite: It slows down the digestive process, helping you feel fuller for longer, thus reducing overall calorie intake.
- Slow down how quickly food leaves the stomach.
- By acting on hunger-regulating hormones, it decreases food cravings.
Mounjaro is recommended as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity, in adults, only if they have:
- an initial body mass index (BMI) of at least 35 kg/m2 and
- at least 1 weight-related comorbidity.
Medical Guidance: Mounjaro should be used under the supervision of a healthcare professional. It is not suitable for everyone, particularly those with a history of certain thyroid conditions or pancreatic disorders.
Lifestyle Integration: For the best results, Mounjaro should be used alongside a balanced diet and regular physical activity.
Weight Maintenance: Maintaining weight loss after stopping the medication may require continued lifestyle changes and potential alternative treatments.
If a dose is missed, administer MOUNJARO as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.